References
1. Angulo PJNEJoM. Nonalcoholic fatty liver disease. 2002; 346 : 1221-31.
2. Ahmed MH, Husain NEO, Almobarak AOJJofm, care p. Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? 2015; 4 : 45.
3. Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CAJAoh. Metabolic syndrome and non-alcoholic fatty liver disease. 2009; 8 : 18-24.
4. Esteghamati A, Noshad S, Khalilzadeh O et al. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. 2011; 9 : 111-7.
5. Brunt EM, Wong VW-S, Nobili V et al. Nonalcoholic fatty liver disease. 2015; 1 : 1-22.
6. Dong F, Zhang Y, Huang Y et al. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. 2016; 6 : 36783.
7. Dunkler D, Kohl M, Teo KK et al. Population-attributable fractions of modifiable lifestyle factors for CKD and mortality in individuals with type 2 diabetes: a cohort study. 2016; 68 : 29-40.
8. Stefan N, Häring H-UJD. The metabolically benign and malignant fatty liver. 2011; 60 .
9. Bugianesi E, Gastaldelli A, Vanni E et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. 2005; 48 : 634-42.
10. Harwood Jr HJJN. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. 2012; 63 : 57-75.
11. McGown C, Birerdinc A, Younossi ZMJCild. Adipose tissue as an endocrine organ. 2014; 18 : 41-58.
12. Balsan GA, Vieira JLdC, Oliveira AMd, Portal VLJRdAMB. Relationship between adiponectin, obesity and insulin resistance. 2015; 61 : 72-80.
13. Park P-H, Sanz-Garcia C, Nagy LEJCpr. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. 2015;3 : 243-52.
14. Fantuzzi G, Faggioni RJJolb. Leptin in the regulation of immunity, inflammation, and hematopoiesis. 2000; 68 : 437-46.
15. Friedman JMJTKjom. Leptin and the regulation of body weigh. 2011;60 : 1-9.
16. Cohen B, Novick D, Rubinstein MJS. Modulation of insulin activities by leptin. 1996; 274 : 1185-8.
17. Pagano G, Pacini G, Musso G et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. 2002; 35 : 367-72.
18. Ali B, Blunden GJPRAijdtp, derivatives teonp. Pharmacological and toxicological properties of Nigella sativa. 2003; 17 : 299-305.
19. Abdelmeguid NE, Fakhoury R, Kamal SM, Al Wafai RJJJod. Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β‐cells of streptozotocin‐induced diabetic rats. 2010;2 : 256-66.
20. Kanter M, Akpolat M, Aktas CJJomh. Protective effects of the volatile oil of Nigella sativa seeds on β-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study. 2009; 40 : 379-85.
21. Mansi KMSJPJoBS. Effects of oral administration of water extract of Nigella sativa on serum concentrations of insulin and testosterone in alloxan-induced diabetic rats. 2005; 8 : 1152-6.
22. Dahri AH, Chandio AM, Rahoo AA, Memon RAJJoAMCA. Effect of Nigella sativa (kalonji) on serum cholesterol of albino rats. 2005; 17 .
23. Mollazadeh H, Hosseinzadeh HJIjobms. The protective effect of Nigella sativa against liver injury: a review. 2014; 17 : 958.
24. Kono T, Asama T, Chisato N et al. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats. 2012; 90 : 122-30.
25. Kaleem M, Kirmani D, Asif M et al. Biochemical effects of Nigella sativa L seeds in diabetic rats. 2006.
26. Dehkordi FR, Kamkhah AFJF, pharmacology c. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. 2008;22 : 447-52.
27. Chan CK, Zhao Y, Liao SY et al. A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium. 2013; 4 : 122-9.
28. Jaarin K, Foong WD, Yeoh MH et al. Mechanisms of the antihypertensive effects of Nigella sativa oil in L-NAME-induced hypertensive rats. 2015; 70 : 751-7.
29. Badar A, Kaatabi H, Bamosa A et al. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. 2017; 37 : 56-63.
30. Datau E, Surachmanto E, Pandelaki K, Langi JJAMI. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. 2010; 42 : 130-4.
31. Mahdavi R, Alizadeh M, Namazi N, Farajnia SJJoHM. Changes of body composition and circulating adipokines in response to Nigella sativa oil with a calorie restricted diet in obese women. 2016; 6 : 67-72.
32. Bahgat NM, Soliman GZJJAS. Effect of Nigella sativa supplementation in diet on metabolic syndrome in aged Rats. 2011; 7 : 577-83.
33. GÜLLÜ EB, Gülcan AJKUVFD. Effects of thymoquinone on plasma leptin, insulin, thyroid hormones and lipid profile in rats fed a fatty diet. 2013; 19 : 1011-6.
34. Sayeed MSB, Asaduzzaman M, Morshed H et al. The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers. 2013; 148 : 780-6.
35. Qidwai W, Hamza HB, Qureshi R et al. Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial. 2009;15 : 639-44.
36. Amin F, Islam N, Anila N, Gilani AJCtim. Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome–A double blind randomized controlled trial–TAK-MetS trial. 2015; 23 : 165-74.
37. Najmi A, Nasiruddin M, Khan R, Haque SFJAJPCR. Indigenous herbal product Nigella sativa proved effective as an antihypertensive in metabolic syndrome. 2013; 6 : 61-4.
38. Sahebkar A, Soranna D, Liu X et al. A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure. 2016; 34 : 2127-35.
39. Doménech M, Roman P, Lapetra J et al. Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial. 2014; 64 : 69-76.